Korea
Siita, the world's first zero-waste company
NEW YORK, March 9, 2023 /PRNewswire/ -- Following announcement covered by Korea Herald, South Korean vegan cosmetics brand Siita said Thursday (Mar 2nd) that it has been recognized as one of the first zero waste companies globally by a sustainable fashion and lifestyle platform affiliated with th...
Hyundai Mobis pushes the boundaries of safety innovations with breakthrough airbag technology
* Brain Injury Prevention Airbag gets a perfect score from the US' Obilique crash test and wins the Silver Tower Order of Industrial Service Merit in the government-held New Technology Commercialization Competition. * The company unveiled various innovations including Face-to-face Protection ...
BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events
CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ --
BIORCHESTRA
Wonderers, A New Action-Adventure Game To Start Closed Beta Test Soon
* A multi-genre action-adventure game including roguelike and MOBA, social features, and more * Create your own story in a fairy tale realm brought to life by adorable characters and sophisticated graphics SEOUL, South Korea, March 7, 2023 /PRNewswire/ -- Wonderers: Eternal World, a new actio...
Hyundai Mobis Introduces Electronic Leveling Control for EVs and PBVs
* ELC co-developed with Hyundai Motor Company to protect EV batteries, increase driving range, and make it easier to get on and off vehicles. * The system adjusts the height by up to 6 cm in various circumstances, including rough roads, highways, and parking lots. * Provides features seen in...
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis
* The trial met its primary endpoint and key secondary endpoints, with a favorable safety profile * Batoclimab is one of the most advanced FcRn inhibitors being developed in Greater China for the treatment of myasthenia gravis SEOUL, South Korea, March 6, 2023 /PRNewswire/ -- HanAll Biopharma...
SurplusGLOBAL Announces Executive Promotion, Recruitment, and Establishment of Equipment Technology Team
SEOUL, South Korea, March 3, 2023 /PRNewswire/ -- SurplusGLOBAL, the leading
global platform company for pre-owned semiconductor equipment (
www.SurplusGLOBAL.com
Neurophet to unveil new technology for analyzing ARIA side effect at ECR 2023
* Introducing brain imaging analysis solutions including Neurophet AQUA and Neurophet SCALE PET * Unveiling technology to analyze and monitor ARIA, side effect of anti-amyloid antibody drug for Alzheimer's disease SEOUL, South Korea, March 2, 2023 /PRNewswire/ -- Neurophet, an artificial inte...
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA
* ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. * Cellosome™ HA fillers are expected to be approved in 2023. * ExoCoBio has all 3 types of GMP clearance for pharmaceuticals, medical devices, & cosmetics. SEOUL, South Korea, March 2, 2023 /PRNewswire/ -...
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
* Entered into an acquisition deal of 3 programs YONGIN, South Korea, Feb. 27, 2023 /PRNewswire/ -- GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that it has signed an Asset Purchase Agreement with Catalyst Biosciences (NASDAQ : ...
LG Innotek to lead the future device market with high-performance 2-Metal COF
* Supporting high-resolution display... Expected to increase the level of immersion for users. * Flexibility and unbounded design with thin films * Creating differentiated customer values with 2-Metal Chip on Film (COF) highlighting 50 years of substrate business SEOUL, South Korea, Feb. 27...
Oysterable Showcases AIoT Smart Resource Circulation Solution 'Lalaloop' at MWC2023
* Lalaloop© AIoT resource circulation solution enables lifecycle data management of resources from manufacturing to reprocessing via LalaloopID© and AIoT self-serve Reverse Vending Machine (RVM). * It tracks individual and corporate carbon emissions and has been recognized as the smartest sol...
PiQuant Wins CES 2023 Innovation Award for Spectroscopy-based Detection Tool
SEOUL, South Korea, Feb. 26, 2023 /PRNewswire/ -- PiQuant- Co., Ltd. (CEO:
Doyeon Pi), a spectroscopy-based environmental IoT company, has won the CES
2023 Innovation Award from the Consumer Technology Association (CTA) of America.
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib
* With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving the door open for partnership PANGYO, South Korea, Feb. 24, 2023 /PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of cevidop...
Rayence unveils the first X-ray detector technology utilizing SPAD technology
* Presenting the cutting-edge detector technology, 'SPAD-GS', which is 2.5 times more sensitive to X-rays and 4 times faster than ever * Implemented the world's first X-ray detector using the 'SPAD', digital pixel technology capable of single-photon detection * Being announced and drawing at...
Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration
* Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea® Biosimilar (ALT-L9) clinical development and licensing-out discussions. * Early 2024 projected for Phase 3 completion and product launch in Europe expected after obtaining approval in the first half of 2025. DAEJEON, So...
MAXST will Showcase Metaverse Service Development Platform at MWC 2023
SEOUL, South Korea and BARCELONA, Spain, Feb. 22, 2023 /PRNewswire/ -- MAXST
Co., Ltd., a company specializing in the metaverse platform, will participate
in MWC 2023 (Mobile World Congress 2023), held inBarcelona, Spain from February
27 to March 2.
Bridge Biotherapeutics Presents Phase 2a Clinical Trial Results For BBT-401, a Drug Candidate to Treat Ulcerative Colitis
* BBT-401 meets safety endpoints achieved in previous clinical studies * The drug candidate did not achieve an improved clinical response compared to the placebo study group * 54.5% of the treatment cohort exhibited a valid treatment response to orally administered BBT-401 SEONGNAM, South Ko...
EM Coretech to Mass-Produce World's First EMIC Next Year
SEOUL, South Korea, Feb. 20, 2023 /PRNewswire/ -- EM Coretech, working with a Korean 8-in semiconductor foundry, is mass-producing the world's first electromagnetic interference management IC (EMIC). An EMIC removes electromagnetic waves generated by electronic parts and prevents device malfunct...
Celltrion and LISCure Biosciences announce strategic collaboration to develop novel microbiome treatment for Parkinson's disease
* Co-research and co-development of novel microbiome therapeutics * Discovery of new candidates to meet high unmet medical needs in Parkinson's disease SEOUL, South Korea, Feb. 20, 2023 /PRNewswire/ -- LISCure Biosciences Inc., a clinical-stage biotech developing advanced microbiome technology...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00